CAS: 1389264-17-8
Acetamide, N-[2-(diethylamino)ethyl]-2-[[2-[[(4-fluorophenyl)methyl]thio]-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-
CAS:1389264-17-8
Formula:
C36H38F4N4O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
666.7711
Ref: IN-DA0019UL
1mg | 245.00 € | ||
5mg | 534.00 € | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Darapladib-impurity
CAS:1389264-17-8
Darapladib-impurity is the impurity of Darapladib. Darapladib inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).
Formula:
C36H38F4N4O2S
Purity:
98.04%
Color and Shape:
Solid
Molecular weight:
666.77
Ref: TM-T31204
1mg | 182.00 € | ||
5mg | 415.00 € | ||
10mg | 612.00 € | ||
25mg | 916.00 € | ||
50mg | 1,287.00 € | ||
100mg | 1,762.00 € | ||
500mg | 3,520.00 € |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Darapladib-impurity
Controlled ProductCAS:1389264-17-8
Applications Darapladib-impurity (cas# 1389264-17-8) is a useful research chemical.
Formula:
C36H38N4O2F4S
Color and Shape:
Neat
Molecular weight:
666.77
Ref: TR-D194925
10mg | 112.00 € | ||
50mg | 348.00 € | ||
100mg | 529.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Darapladib-impurity
CAS:1389264-17-8
Please enquire for more information about Darapladib-impurity including the price, delivery time and more detailed …
Formula:
C36H38N4O2F4S
Purity:
Min. 95%
Molecular weight:
666.77 g/mol
Ref: 3D-PFC26417
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 25 Nov 2024